Randomized Control Trial Comparing Efficacy of a Single Dose of Treatment of Yaws with 20 mg/kg Versus 30 mg/kg of Azithromycin

Non-inferiority study comparing a 20mg/kg dosing strategy of azithromycin to a 30mg/kg dosing strategy in the treatment of yaws 

Sites

Sample size: 600
Implementation partner(s): Papa New Guinea MOH | WHO
WHO Region: WPRO

Implementation partner(s): Ghana MOH | WHO
WHO Region: AFRO

Publications

Knowledge, attitudes and practices towards yaws and yaws-like skin disease in Ghana

Michael Marks et al.
2017, Issue no. 11, pages 7

Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea

Michael Marks, Oriol Mitjà, Cynthia Kwakye, et al.
2018, Issue no. 6(4), pages e401–e410

Notes

ClinicalTrials.gov Identifier: NCT02344628

ClinicalTrials.gov Link: http://clinicaltrials.gov/show/NCT02344628

Email primary contact

Please log in or register